English
Explore context
Precision Medicine
Explore the latest strategic trends, research and analysis
Global Issue
Industry
Economy
4th Industrial Revolution
Global Issue
Industry
Economy
4th Industrial Revolution
Precision Medicine
Explore context
COVID-19
Half of those surveyed are unaware of the link between climate change and diseases like COVID-19
Public concern about climate change has risen, but a study shows that widespread lack of knowledge exists regarding how rising temperatures impact the spread of disease.
COVID-19
This is what we know about the new COVID-19 variant, according to an expert
Lucy van Dorp, an expert in microbial genomics, answers key questions about the new COVID-19 variant, including how effective the vaccine will be against it.
COVID-19
Equal access to COVID-19 vaccines could be worth billions
By averting economic disaster and helping to end the pandemic, 10 major economies could be $466 billion better off by 2025, new data finds.
COVID-19
Asian Development Bank launches $9 billion COVID-19 vaccine facility
The Asia Pacific Vaccine Access Facility (APVAX), will provide support for procurement and transporting of vaccines from place of purchase to ADB’s developing members.
COVID-19
COVID-19: 3 important questions about vaccines, answered by an expert
An immunologist has answered questions surrounding COVID-19, such as the safety of a second dose, being in a trial previously and coronavirus re-infection.
COVID-19
'We're ready': Schiphol airport gears up for chilled vaccine cargos
At Amsterdam’s Schiphol Airport, KLM workers are preparing to ship COVID-19 vaccines made in Europe around the world.
COVID-19
UNICEF will ship 2 billion COVID-19 vaccines to developing nations in 2021
UNICEF will work with over 350 airlines and freight companies to deliver nearly 2 billion COVID-19 vaccines to developing countries next year.
Precision Medicine
AstraZeneca's COVID-19 vaccine 90% effective, results show
AstraZeneca's vaccine for COVID-19 could be around 90% effective without any serious side effects. The vaccine can also be refrigerated, rather than frozen.
COVID-19
We may have to accept a ‘good enough’ COVID-19 vaccine, at least in 2021
For COVID-19 vaccines, individuals, governments and regulators will need to think through safety, efficacy and equitability concerns, write three health experts.
Global Health
How to stop drug-resistant superbugs from causing the next pandemic
By 2050, AMR could cause 10 million deaths annually. It's vital that governing bodies help to incentivize the industry, writes AMR expert Thomas Cueni.
Precision Medicine
Pfizer vaccine trial ends with 95% success rate
Pfizer said its two-dose vaccine, BNT162b2, was consistently effective across different ages and ethnic groups, well-tolerated and that side effects were mostly mild to moderate.
Internet Governance
YouTube bans coronavirus vaccine misinformation
The video platform said it would now ban any content with claims about COVID-19 vaccines that contradict consensus from local health authorities or the World Health Organization.
Precision Medicine
Citizens in these countries have the most trust in scientists
Around the world, scientists have more credibility than the government, the media or business leaders, according to the Pew Research Center.
COVID-19
40% of world's plants at risk of extinction, new report finds
The loss of biodiversity means the world is losing plants with the potential to act as food, fuel and medicine.
COVID-19
WHO reveals corticosteroids are effective in reducing the fatality rate of COVID-19
When severely ill COVID-19 patients are treated with corticosteroids such as dexamethasone, their survival rates increase according to the World Health Organization.